Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes

Gastroenterology

Volumn 144, Issue 4, 2013, Pages 829-840

  Sia, Daniela ^a,b   Hoshida, Yujin ^c   Villanueva, Augusto ^a,d   Roayaie, Sasan ^c   Ferrer, Joana ^e   Tabak, Barbara ^f   Peix, Judit ^a,d   Sole, Manel ^a   Tovar, Victoria ^a   Alsinet, Clara ^a   Cornella, Helena ^a   Klotzle, Brandy ^g   Fan, Jian Bing ^g   Cotsoglou, Christian ^b   Thung, Swan N ^c   Fuster, Josep ^a,e   Waxman, Samuel ^c   Garcia Valdecasas, Juan Carlos ^e   Bruix, Jordi ^a,d   Schwartz, Myron E ^c   Beroukhim, Rameen ^f,h   Mazzaferro, Vincenzo ^b   Llovet, Josep M ^a,c,d,i   more..

^a UNIVERSITY OF BARCELONA   (Spain)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

^e HOSPITAL CLÍNIC   (Spain)

^f BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^g ILLUMINA INC   (United States)

^h DANA FARBER CANCER INSTITUTE   (United States)

ⁱ INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

Liver Cancer; Molecular Classification; Prognosis; Whole Genome Profiling

Indexed keywords

B RAF KINASE; CYTOKINE; EPIDERMAL GROWTH FACTOR; FORMALDEHYDE; I KAPPA B KINASE BETA; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 4; MITOGEN ACTIVATED PROTEIN KINASE; PLATELET DERIVED GROWTH FACTOR; PROTEIN KINASE B; RAS PROTEIN; SCATTER FACTOR RECEPTOR; STAT3 PROTEIN; VASCULOTROPIN;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER DIAGNOSIS; CANCER SURVIVAL; CELL ACTIVATION; CHROMOSOME 11Q; CHROMOSOME 14Q; CHROMOSOME 1P; CHROMOSOME 9P; CONTROLLED STUDY; COPY NUMBER VARIATION; DENDRITIC CELL; DISEASE CLASSIFICATION; DNA MICROARRAY; FEMALE; GENE AMPLIFICATION; GENE CLUSTER; GENE DELETION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ALGORITHM; GENETIC ANALYSIS; GENETIC TRAIT; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84875244110     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2013.01.001     Document Type: Article

References (51)

1. B.R. Bleachacz, G.J. Gores Cholangiocarcinoma Clin Liver Dis 12 2008 131 150
2. C. Sempoux, G. Jibara, S. Ward Intrahepatic cholangiocarcinoma: new insights in pathology Semin Liver Dis 31 2011 104 110
3. S.A. Khan, S.D. Taylor-Robinson, M.B. Toledano Changing international trends in mortality rates for liver, biliary and pancreatic tumours J Hepatol 37 2002 806 813
4. P. Singh, T. Patel Advances in the diagnosis, evaluation and management of cholangiocarcinoma Curr Opin Gastroenterol 22 2006 294 299
5. J. Valle, H. Wasan, D.H. Palmer Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer N Engl J Med 362 2010 1273 1281
6. J.C. Tan, N.G. Coburn, N.N. Baxter Surgical management of intrahepatic cholangiocarcinoma-a population-based study Ann Surg Oncol 15 2008 600 608
7. D. Sia, V. Tovar, A. Moeini Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies Oncogene 2013 Jan 14 Epub ahead of print
8. H. Wehbe, R. Henson, F. Meng Interleukin-6 contributes to growth in cholangiocarcinoma cells by aberrant promoter methylation and gene expression Cancer Res 66 2006 10517 10524
9. H. Isomoto, S. Kobayashi, N.W. Werneburg Interleukin 6 upregulates myeloid cell leukemia-1 expression through a STAT3 pathway in cholangiocarcinoma cells Hepatology 42 2005 1329 1338
10. A. Tannapfel, M. Benicke, A. Katalinic Frequency of p16 (INK4A) alterations and K-ras mutations in intrahepatic cholangiocarcinoma of the liver Gut 47 2000 721 727
11. H. Momoi, T. Itoh, Y. Nozaki Microsatellite instability and alternative genetic pathway in intrahepatic cholangiocarcinoma J Hepatol 35 2001 235 244
12. T. Terada, Y. Nakanuma, A.E. Sirica Immunohistochemical demonstration of MET overexpression in human intrahepatic cholangiocarcinoma and in hepatolithiasis Hum Pathol 29 1998 175 180
13. T. Terada, K. Ashida, K. Endo c-erbB-2 protein is expressed in hepatolithiasis and cholangiocarcinoma Histopathology 33 1998 325 331
14. J.M. Llovet, S. Ricci, V. Mazzaferro SHARP Investigators Study Group Sorafenib in advanced hepatocellular carcinoma N Engl J Med 359 2008 378 390
15. C. Bengala, F. Bertolini, N. Malavasi Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial Br J Cancer 102 2010 68 72
16. J.P. Brunet, P. Tamayo, T.R. Golub Metagenes and molecular pattern discovery using matrix factorization Proc Natl Acad Sci U S A 101 2004 4164 4169
17. J.S. Lee, I.S. Chu, J. Heo Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling Hepatology 40 2004 667 676
18. H.G. Woo, J.H. Lee, J.H. Yoon Identification of a cholangiocarcinoma-like gene expression trait in hepatocellular carcinoma Cancer Res 70 2010 3034 3041
19. S. Boyault, D.S. Rickman, A. de Reyniès Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets Hepatology 45 2007 42 52
20. Y. Hoshida, S.M. Nijman, M. Kobayashi Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma Cancer Res 69 2009 7385 7392
21. J.F. Bromberg, M.H. Wrzeszczynska, G. Devgan Stat3 as an oncogene Cell 98 1999 295 303
22. A. Gentile, L. Lazzari, S. Benvenuti Ror1 is a pseudokinase that is crucial for Met-driven tumorigenesis Cancer Res 71 2011 3132 3141
23. A. Montpetit, G. Boily, D. Sinnett A detailed transcriptional map of the chromosome 12p12 tumour suppressor locus Eur J Hum Genet 10 2002 62 71
24. K.P. Lee, J.H. Lee, T.S. Kim The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis Proc Natl Acad Sci U S A 107 2010 8248 8253
25. J.B. Andersen, B. Spee, B.R. Blechacz Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors Gastroenterology 142 2012 1021 1031.e15
26. N. Oishi, M.R. Kumar, S. Roessler Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of mir-200c and EMT in intrahepatic cholangiocarcinoma Hepatology 56 2012 1792 1803
27. H.T. Zhang, M. Gorn, K. Smith Transcriptional profiling of human microvascular endothelial cells in the proliferative and quiescent state using cDNA arrays Angiogenesis 3 1999 211 219
28. M.C. de Jong, H. Nathan, G.C. Sotiropoulos Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment J Clin Oncol 29 2011 3140 3145
29. L. Wang, T. Yi, M. Kortylewski IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway J Exp Med 206 2009 1457 1464
30. H. Isomoto, J.L. Mott, S. Kobayashi Sustained IL-6/STAT-3 signaling in cholangiocarcinoma cells due to SOCS-3 epigenetic silencing Gastroenterology 132 2007 384 396
31. R.D. Schreiber, L.J. Old, M.J. Smyth Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion Science 331 2011 1565 1570
32. T. Roskams Liver stem cells and their implication in hepatocellular and cholangiocarcinoma Oncogene 25 2006 3818 3822
33. D.Y. Chiang, A. Villanueva, Y. Hoshida Focal gains of VEGFA and molecular classification of hepatocellular carcinoma Cancer Res 68 2008 6779 6788
34. B. Blechacz, G.J. Gores Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment Hepatology 48 2008 308 321
35. J.F. Rossi, S. Négrier, N.D. James A phase I/II study of siltuximab (CNTO 328), an anti-interleukin-6 monoclonal antibody, in metastatic renal cell cancer Br J Cancer 103 2010 1154 1162
36. S. Verstovsek, H. Kantarjian, R.A. Mesa Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis N Engl J Med 363 2010 1117 1127
37. A.G. Wang, S.Y. Yoon, J.H. Oh Identification of intrahepatic cholangiocarcinoma related genes by comparison with normal liver tissues using expressed sequence tags Biochem Biophys Res Commun 345 2006 1022 1032
38. N. Jinawath, Y. Chamgramol, Y. Furukawa Comparison of gene expression profiles between Opisthorchis viverrini and non-Opisthorchis viverrini associated human intrahepatic cholangiocarcinoma Hepatology 44 2006 1025 1038
39. G. Miller, N.D. Socci, D. Dhall Genome wide analysis and clinical correlation of chromosomal and transcriptional mutations in cancers of the biliary tract J Exp Clin Cancer Res 28 2009 62
40. B. Yang, M.G. House, M. Guo Promoter methylation profiles of tumor suppressor genes in intrahepatic and extrahepatic cholangiocarcinoma Mod Pathol 18 2005 412 420
41. E. Karamitopoulou, L. Tornillo, I. Zlobec Clinical significance of cell cycle- and apoptosis-related markers in biliary tract cancer: a tissue microarray-based approach revealing a distinctive immunophenotype for intrahepatic and extrahepatic cholangiocarcinomas Am J Clin Pathol 130 2008 780 786
42. A.F. Hezel, V. Deshpande, A.X. Zhu Genetics of biliary tract cancers and emerging targeted therapies J Clin Oncol 28 2010 3531 3540
43. L. Chin, J.N. Andersen, P.A. Futreal Cancer genomics: from discovery science to personalized medicine Nat Med 17 2011 297 303
44. H. Davies, G.R. Bignell, C. Cox Mutations of the BRAF gene in human cancer Nature 417 2002 949 954
45. M. Soda, Y.L. Choi, M. Enomoto Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer Nature 448 2007 561 566
46. K.T. Flaherty, I. Puzanov, K.B. Kim Inhibition of mutated, activated BRAF in metastatic melanoma N Engl J Med 363 2010 809 819
47. B.A. Chabner Early accelerated approval for highly targeted cancer drugs N Engl J Med 364 2011 1087 1089
48. A. Stokes, I. Drozdov, E. Guerra Copy number and loss of heterozygosity detected by SNP array of formalin-fixed tissues using whole-genome amplification PLoS One 6 2011 e24503
49. D. Quandt, E. Fiedler, D. Boettcher B7-h4 expression in human melanoma: its association with patients' survival and antitumor immune response Clin Cancer Res 17 2011 3100 3111
50. A.E. Krambeck, R.H. Thompson, H. Dong B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival Proc Natl Acad Sci U S A 103 2006 10391 10396
51. L. Lu, Y. Li, S.M. Kim Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver Proc Natl Acad Sci U S A 107 2010 1437 1442